Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 27, 2009

Premium

Alnylam Pharmaceuticals announced that CSO John Schmidt is leaving the company, less than a year after he joined the RNAi drugs shop.

Alnylam did not provide a reason for the departure. According to a company filing with the US Securities and Exchange Commission, Schmidt will officially step down on Sept. 30.


RXi Pharmaceuticals said that CFO and Executive Vice President of Business Operations Stephen DiPalma has resigned to pursue other opportunities.

The resignation will be effective Aug. 28, according to a company filing with the US Securities and Exchange Commission.

RXi said it will recruit a new CFO.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.